Related Experiment Video
Updated: Mar 29, 2026

Quail Chorioallantoic Membrane - A Tool for Photodynamic Diagnosis and Therapy
Published on: April 28, 2022
Pachychoroid-Related Pigment Epithelial Detachment Treated with Photodynamic Therapy
Maciej Gawęcki1,2, Karolina Mach1, Krzysztof Kiciński1,2
1Dobry Wzrok Ophthalmological Center, 80-392 Gdansk, Poland.
Half-dose photodynamic therapy (hd-PDT) effectively treated pachychoroid pigment epitheliopathy (PPE), improving vision and reducing PED height. Central lesions showed better outcomes, suggesting hd-PDT is a viable option for this condition.
Area of Science:
- Ophthalmology
- Medical Imaging
- Retinal Diseases
Background:
- Pachychoroid pigment epitheliopathy (PPE) is a pachychoroid spectrum disease with increased choroidal thickness and isolated pigment epithelial detachment (PED).
- Efficacy of photodynamic therapy (PDT) for isolated PPE is not well-defined, with limited evidence from small case series.
Purpose of the Study:
- Characterize symptomatic pachychoroid-related PED.
- Evaluate anatomical and functional outcomes of half-dose PDT (hd-PDT).
- Analyze outcomes based on lesion localization and history of central serous chorioretinopathy (CSC).
Main Methods:
- Retrospective study of 34 eyes treated with hd-PDT.
- Categorization of PEDs as central or paramacular.
- Assessment of best-corrected visual acuity (BCVA) and OCT parameters (CST, MST, MV, SFCT, PED height) at baseline, 1, and 6 months.
- Treatment planning guided by ICGA and SD-OCT.
Main Results:
- Complete PED resorption in 73.5% of eyes by 6 months, with higher rates for central lesions.
- Significant BCVA improvement from 0.22 to 0.10 logMAR at 6 months, with greater gain in central lesions.
- Reduced CST, MST, MV, and PED height; stable SFCT. Younger age, shorter duration, smaller baseline volume, and absence of CSC history correlated with better outcomes.
Conclusions:
- hd-PDT demonstrates favorable anatomical and functional outcomes in symptomatic pachychoroid-related PED.
- Centrally located lesions and baseline disease severity influence treatment response.
- Further prospective studies are needed to confirm long-term efficacy and safety.
More Related Videos
04:43Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
Published on: May 23, 2025
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023